Pinealon (EDR)

The name identifies a research subject in these publications; it does not independently verify the identity, purity, or analytical characterization of any particular test article. Keep the source’s exact compound designation and preparation attached to each record.

This opening visual is conceptual artwork, not a molecular structure, assay, product analysis, or experimental result. The research file focuses on what the cited papers actually tested and where their conclusions stop.

• Reported sequence: Glu-Asp-Arg (EDR)
• Synthetic short-peptide research designation
• A paper’s material description is not batch-specific verification

Khavinson and colleagues studied cerebellar granule cells, neutrophils, and PC12 cells under specified experimental conditions. The paper reports measurements involving reactive oxygen species and cell viability. These are observations in the tested cell systems, not evidence of a clinical effect or a universal mechanism.

Interpret each endpoint through its assay, controls, concentration conditions, and cell model. The illustration is a microscopy-inspired editorial scene only; it does not reproduce the paper’s data or assert an outcome beyond its source.

• 2011 in-vitro study across named cell systems
• Measured endpoints included ROS-related signals and viability
• Cell-culture observations remain specific to those models and methods

Fedoreyeva and colleagues reported cellular localization observations for labeled peptides and in-vitro experiments involving deoxyribooligonucleotides and DNA. The paper also discussed computational modeling. Localization, an in-vitro interaction, and a modeled binding pose are different types of evidence; none alone establishes a validated in-vivo gene-regulatory mechanism for Pinealon.

A 2021 review discusses proposed short-peptide interactions with DNA and histone proteins across a broader literature. It is a review of a research hypothesis and related records, not an independent confirmation that every proposed mechanism applies to Pinealon in every system.

• Labeled-cell localization and in-vitro interaction experiments are distinct methods
• Modeling is not direct measurement of an in-vivo mechanism
• Do not promote a proposed gene-regulation model to an established target

Arutjunyan and colleagues described a rat study with defined experimental groups and reported behavioral and cellular measurements, including spatial-orientation and learning tasks in offspring and oxidative-stress-related measures in isolated cerebellar cells. Those observations belong to that particular animal model, experimental setup, and paper.

The study does not establish a general effect beyond its model or resolve how well its findings translate to other research settings. Read the full methods, group assignment, endpoints, and limitations rather than treating a conceptual comparison graphic as study data.

• 2012 paper: a specified prenatal rat model
• Behavioral and cellular measurements were distinct endpoints
• Animal-model results do not establish clinical relevance

The cited cell studies, localization experiments, and rat-model report address different questions and must not be blended into one conclusion. A review can organize proposed mechanisms, but the underlying primary methods determine what was directly measured.

A careful evidence read checks test-article identity, model, comparator, assay, endpoint, replication, and source limitations. The illustration closes on separate evidence lanes and unresolved nodes; it is not molecular docking, experimental data, or an outcome prediction.

• Keep model-specific findings attached to their original source
• Distinguish measurement, interpretation, and hypothesis
• No clinical efficacy or defined therapeutic mechanism is established by these records